The webinar, led by Prof. Bart Van Wijmeersch, explores the critical importance of prognostic tools in multiple sclerosis (MS) care.The session highlights the MS Prognosis Scorecard, a practical framework that helps clinicians predict clinical outcomes and make informed, individualised treatment decisions. Combining clinical, radiological, and biological factors, the Scorecard enables a more precise prognosis, supporting tailored strategies to slow disease progression and improve patient outcomes.“MS Prognosis Scorecard: A Tool for Predicting Clinical Outcomes“.
Please subscribe...
IntroductionThe current methods for MS prognostication often focus on physical disability, leaving gaps in understanding the broader impact of MS. This study investigates how neurologists integrate prognostication into their practice and identifies key areas requiring attention to improve decision-making. By capturing the perspectives of MS specialists, the research highlights the need for standardized, patient-centred approaches that go beyond traditional disease metrics.In this post, we share the latest findings from a qualitative study, by Sofie Aerts, a PhD Researcher, who presented at ECTRIMS...
Key takeawaysLimitations of EDSS – The EDSS alone may not capture the full scope of MS progression, especially in cases where deterioration occurs independently of relapses (PIRA).
Smoldering MS – MS can progress silently, with neurodegeneration happening beneath the surface, even when clinical symptoms seem stable. This requires a broader monitoring strategy.
Multimodal Monitoring – Effective disease monitoring should go beyond neurological exams, integrating:Clinical assessments and patient-reported outcomes (PROs)
Imaging techniques, such as MRI biomarkers and advanced neuroimaging
Biomarkers...
BIOGRAPHY
Bart Van Wijmeersch
Bart Van Wijmeersch is a neurologist specialized in Multiple Sclerosis. He is medical director of the Rehabilitation and MS Center in Pelt where he leads the multidisciplinary MS-team. Furthermore, he is an associate professor of Neurology at the University of Hasselt, affiliated with the Biomedical Institute, where he’s involved in pre-clinical as well as the clinical research on MS at the biomedical institute (BIOMED). He has a supporting role in all the immunological research on blood- and CSF samples of persons with MS and in EAE-animal models, as well as in...
Navigate to this page to start this elearning.This e-learning module is part of a series of 5 e-learnings created by ParadigMS on Prognostication, high efficacy treatments and virtual care in MS. Each module has a lead author and several contributors, all are neurologists with an expertise in multiple sclerosis and members of ParadigMS.You will receive an EACCME certificate upon completing the e-learning and successfully passing an exam.
Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material.
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately.
ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.
Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.
Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.